Valuation : Samil Pharmaceutical Co.,Ltd

Market Cap 133B 96.29M 82.97M 77.8M 71.02M 134M 9.2B 134M 923M 360M 4.65B 362M 354M 15.4B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 299M 217K 187K 175K 160K 301K 20.71M 302K 2.08M 811K 10.46M 814K 796K 34.67M EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.15x
Free-Float
71.64%
Yield 2026 *
-
Yield 2027 * -
1 day+1.47%
1 week+0.16%
Current month+0.16%
1 month+6.52%
3 months-16.31%
6 months-44.45%
Current year-35.91%
1 week 5,910
Extreme 5910
6,400
1 month 5,910
Extreme 5910
7,320
Current year 5,500
Extreme 5500
12,860
1 year 5,500
Extreme 5500
12,860
3 years 5,500
Extreme 5500
19,500
5 years 5,500
Extreme 5500
19,500
10 years 3,154.55
Extreme 3154.545454
29,000
Manager TitleAgeSince
Chief Executive Officer 61 2017-12-31
Chief Executive Officer 45 -
Corporate Officer/Principal 53 2023-03-23
Director TitleAgeSince
Chairman 45 -
Director/Board Member 61 2012-12-31
Director/Board Member 62 2020-03-19
Date Insider Type Main position Quantity % Market Cap.
5/15/25 Buy

Director

772 0.0036%
5/15/25 Buy

Director

1,200 0.0055%
5/15/25 Buy

Director

599 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+0.16%-37.46%-16.76% 96.29M
+0.35%+0.93%+20.41%+72.21% 48.2B
+0.12%-0.20%+53.58%+119.71% 39.97B
+0.15%+6.34%+21.40%+89.62% 12.43B
+0.25%-0.61%-10.44%+15.16% 12.03B
+0.19%0.00%+29.35%+150.00% 9.35B
+0.07%+3.80%+30.19%+51.59% 7.75B
+2.24%+8.50%+30.72%+232.96% 7.43B
-0.79%-0.27%+43.13%-11.73% 7.22B
-0.53%-1.53%-36.09%+17.02% 5.3B
Average +0.35%+2.04%+14.48%+71.98% 14.98B
Weighted average by Cap. +0.25%+1.42%+27.50%+87.45%

Financials

2026 *2027 *
Net sales 235B 171M 147M 138M 126M 237M 16.3B 238M 1.63B 638M 8.23B 640M 626M 27.28B 267B 194M 167M 157M 143M 269M 18.52B 270M 1.86B 725M 9.35B 727M 712M 30.99B
Net income - -
Net Debt 166B 120M 104M 97.31M 88.83M 167M 11.51B 168M 1.15B 450M 5.81B 452M 442M 19.27B 174B 126M 109M 102M 93.11M 175M 12.07B 176M 1.21B 472M 6.09B 474M 464M 20.2B
Logo Samil Pharmaceutical Co.,Ltd
Samil Pharmaceutical Co Ltd is a Korean-based company primarily engaged in the manufacturing and sale of pharmaceuticals. The Company operates through two segments. The Pharmaceutical segment mainly manufactures gastrointestinal motility regulators, nutritional supplements, gastrointestinal treatments, antipyretic analgesics and anti-inflammatory drugs, liver disease treatments and antihistamines, and also sells products used for glaucoma, depression and dry eyes. The Other segment mainly provides related services and also provides rental services. The Company also engages in the development of new drugs for ophthalmic diseases, liver diseases and circulatory and musculoskeletal conditions.
Employees
583
Date Price Change Volume
26-08-28 ₩6,210.00 +1.47% 24,425
26-08-27 ₩6,120.00 -3.01% 38,071
26-08-26 ₩6,310.00 +2.44% 39,003
26-08-25 ₩6,160.00 -1.28% 60,416
26-08-24 ₩6,240.00 +0.65% 391,152
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6,210.00KRW
Average target price
10,000.00KRW
Spread / Average Target
+61.03%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000520 Stock